Scedosporium spp.: Emerging Agents of Systemic Disease

Journal of Invasive Fungal Infections

Volumn 5, Issue 2, 2011, Pages 43-47

  Lackner, Michaela ^a,b   De Hoog, G Sybren ^a,c,d,e  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CALMODULIN; CASPOFUNGIN; MILTEFOSINE; POLYVINYL ALCOHOL; POSACONAZOLE; RIBOSOME DNA; TERBINAFINE; TUBULIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ASEXUAL REPRODUCTION; COUNTER IMMUNOELECTROPHORESIS; HUMAN; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL CARE; PETRIELLIDIUM BOYDII; POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SCEDOSPORIUM; SYSTEMIC DISEASE; TAXONOMY;

EID: 83355172697     PISSN: 17533783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Siebenmann F. Die Schimmelmykosen des Menschlichen Ohres. 2011. Wiesbaden, Germany: J F Bergmann, 2011.
2. Borman AM, Palmer MD, Delhaes L et al. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol 2010;48(Suppl 1):88-97.
3. Harun A, Gilgado F, Chen SC et al. Abundance of Pseudallescheria/ Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Med Mycol 2010;48(Suppl 1):70-6.
4. Paugam A, Baixench MT, Demazes-Dufeu N et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010;48(Suppl 1):32-6.
5. Cortez KJ, Roilides E, Quiroz-Telles F et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21:157-97.
6. Orens JB, Estenne M, Arcasoy S et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55. (Pubitemid 43963375)
7. Morio F, Horeau-Langlard D, Gay-Andrieu F et al. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol 2010;48:1978-82.
8. Symoens F, Knoop C, Schrooyen M et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006;25:603-7.
9. Beguin H, Nolard N. Air and surface analysis of 130 dwellings. Aerobiologia 2010;10:157-66.
10. Leechawengwongs M, Milindankura S, Liengudom A et al. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report. Mycoses 2007;50:512-6. (Pubitemid 47609823)
11. Tigini V, Prigione V, Di TS et al. Isolation and characterisation of polychlorinated biphenyl (PCB) degrading fungi from a historically contaminated soil. Microb Cell Fact 2009;8:5.
12. Kaltseis J, Rainer J, de Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol 2009;47:398-405.
13. Makadia TH, Adetutu EM, Simons KL et al. Re-use of remediated soils for the bioremediation of waste oil sludge. J Environ Manage 2011;92:866-71.
14. Martín-Gil J, Navas-Gracia LM, Gómez-Sobrino E et al. Composting and vermicomposting experiences in the treatment and bioconversion of asphaltens from the Prestige oil spill. Bioresour Technol 2008;99:1821-9.
15. Gilgado F, Gené J, Cano J et al. Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp. nov. Med Mycol 2010;48:122-8.
16. Hell M, Neureiter J, Wonja A et al. Posttraumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male due to surgical intervention and voriconazole therapy. Mycoses 2011; In press.
17. Lackner M, Rezusta A, Villuendas MC et al. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates. Mycoses 2011; In press.
18. Lackner M. Molecular diagnostics and drug resistances in emerging opportunistic fungi of Scedosporium. PhD thesis. Innsbruck, Austria: University of Innsbruck, Institute for Microbiology, 2010.
19. Gilgado F, Cano J, Gené J et al. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005;43:4930-42. (Pubitemid 41483987)
20. Gilgado F, Gené J, Cano J et al. Reclassification of Graphium tectonae as Parascedosporium tectonae gen. nov., comb. nov., Pseudallescheria africana as Petriellopsis africana gen. nov., comb. nov. and Pseudallescheria fimeti as Lophotrichus fimeti comb. nov. Int J Syst Evol Microbiol 2007;57:2171-8. (Pubitemid 47497166)
21. Gilgado F, Cano J, Gené J et al. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008;46:766-71. (Pubitemid 351231334)
22. Gilgado F, Cano J, Gené J et al. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol 2009;47:371-4.
23. Rainer J, Kaltseis J. Diversity in Scedosporium dehoogii (Microascaceae): S. deficiens sp. nov. Sydowia 2010;6:137-42.
24. Issakainen J, Jalava J, Eerola E. et al. Relatedness of Pseudallescheria, Scedosporium and Graphium pro parte based on SSU rDNA sequences. J Med Vet Mycol 1997;35:389-98. (Pubitemid 28037530)
25. Müller FM, Seidler M. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis. Exp Rev Anti Infect Ther 2010;8:957-64.
26. Pihet M, Carrere J, Cimon B et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review. Med Mycol 2009;47:387-97.
27. Rainer J, Kaltseis J, de Hoog GS et al. Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek 2008;93:315-22. (Pubitemid 351167826)
28. Blyth CC, Harun A, Middleton PG et al. Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol 2010;48:314-6.
29. Cimon B, Carrere J, Vinatier JF et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000;19:53-6. (Pubitemid 30093384)
30. Lu Q, Gerrits van den Ende AH, Bakkers JM et al. Identification of Pseudallescheria and Scedosporium species by three molecular methods. J Clin Microbiol 2011;49:960-7.
31. Harun A, Blyth CC, Gilgado F et al. Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 2011;49:1508-12.
32. Coulibaly O, Marinach-Patrice C, Cassagne C et al. Pseudallescheria/ Scedosporium complex species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Med Mycol 2011; In press.
33. de Batlle J, Motjé M, Balanzà R et al. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000;38:1694-5. (Pubitemid 30216719)
34. Mack D, Estes R, McLeod R. Administration of intraliposomal CP20961 to mice activates peritoneal macrophages and augments serum antibody response to Toxoplasma gondii. J Eukaryot Microbiol 1994;41:12.
35. Greig JR, Khan MA, Hopkinson NS et al. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect 2001;43:15-7. (Pubitemid 33019634)
36. Musk M, Chambers D, Chin W et al. Successful treatment of disseminated Scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant 2006;25:1268-72. (Pubitemid 44528282)
37. Bakerspigel A, Kane J, Schaus D. Isolation of Blastomyces dermatitidis from an earthen floor in southwestern Ontario, Canada. J Clin Microbiol 1986;24:890-1. (Pubitemid 17169437)
38. Campbell CK. Polycytella hominis gen. et sp. nov., a cause of human pale grain mycetoma. J Med Vet Mycol 1987;25:301-5. (Pubitemid 18082797)
39. Ben HM, Bedrossian J, Pruna A et al. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient. Transplant Proc 1993;25:2290-1. (Pubitemid 23194102)
40. Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1999;1:229-36.
41. Campagnaro EL, Woodside KJ, Early MG et al. Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transpl Infect Dis 2002;4:207-11. (Pubitemid 36142807)
42. Maertens J, Lagrou K, Deweerdt H et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 2000;79:340-4. (Pubitemid 30349029)
43. Horré R, Jovanic B, Marklein G et al. Fatal pulmonary scedosporiosis. Mycoses 2003;46:418-21. (Pubitemid 37412043)
44. Berenguer J, Diaz-Mediavilla J, Urra D et al. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis 1989;11:890-6.
45. Gopinath M, Cherian A, Baheti NN et al. An elusive diagnosis: Scedosporium apiospermum infection after near-drowning. Ann Indian Acad Neurol 2010;13:213-5.
46. Lam SM, Lau AC, Ma MW et al. Pseudallescheria boydii or Aspergillus fumigatus in a lady with an unresolving lung infiltrate, and a literature review. Respirology 2008;13:478-80. (Pubitemid 351503126)
47. Tekavec J, Mlinarić-Missoni E, Babic-Vazic V. Pulmonary tuberculosis associated with invasive pseudallescheriasis. Chest 1997;111:508-11. (Pubitemid 27096976)
48. Odds FC, Arai T, Disalvo AF et al. Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992;30:1-10.
49. Hung CC, Chang SC, Yang PC et al. Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1994;13:749-51. (Pubitemid 24316577)
50. Zafiro A. Forma singolare di mycosi cutanea da Monosporium apiospermum a sviluppo clinicamente setticemico. Giorn Med Mil 1950;86:636-40.
51. Riddell J, Chenoweth CE, Kauffman CA. Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome. Mycoses 2004;47:442-6. (Pubitemid 39469836)
52. Albernaz V, Huston B, Castillo M et al. Pseudallescheria boydii infection of the brain: imaging with pathologic confirmation. AJNR Am J Neuroradiol 1996;17:589-92. (Pubitemid 26101970)
53. Ong A, Blyth CC, Bency R et al. Fatal mycotic aneurysms due to Scedosporium/Pseudallescheria infection: case reports and literature review. J Clin Microbiol 2011; In press.
54. Malloch D, Salkin IF. A new species of Scedsporium associated with osteomyelitis in humans. Mycotaxon 1984;21:247-55.
55. Rodriguez-Tudela JL, Berenguer J, Guarro J et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009;47:359-70.
56. Benham RW, Georg LK. Allescheria boydii, causative agent in a case of meningitis. J Invest Dermatol 1948;10:99-110.
57. Tintelnot K, Just-Nubling G, Horré R et al. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol 2009;47:351-8.
58. Guarro J, Kantarcioglu AS, Horré R et al. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol. 2006;44:295-327. (Pubitemid 43922066)
59. Kershaw P, Freeman R, Templeton D et al. Pseudallescheria boydii infection of the central nervous system. Arch Neurol 1990;47:468-72. (Pubitemid 20132154)
60. Watanabe S, Hironaga M. An atypical isolate of Scedosporium apiospermum from a purulent meningitis in man. Sabouraudia 1981;19:209-15. (Pubitemid 11025104)
61. Poza G, Montoya J, Redondo C et al. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin Infect Dis 2000;30:981-2. (Pubitemid 32250353)
62. Tintelnot K, Wagner N, Seibold M et al. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning. Mycoses 2008;51(Suppl 3):11-6.
63. Ohashi R, Kato M, Katsura Y et al. Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS). Nippon Ishinkin Gakkai Zasshi 2011;52:33-8.
64. Tong SY, Peleg AY, Yoong J et al. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transpl Infect Dis 2007;9:241-3. (Pubitemid 47231206)
65. Kesson AM, Bellemore MC, O'Mara TJ et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis 2009;48:1257-61.
66. Bhat SV, Paterson DL, Rinaldi MG et al. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007;39:87-90. (Pubitemid 46277156)
67. Howden BP, Slavin MA, Schwarer AP et al. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003;22:111-3. (Pubitemid 36349974)
68. Sheu R, Bricker AO, Sahi H et al. Pseudallescheria boydii (Scedosporium species) in 3 lung transplant recipients: computed tomography findings and literature review. J Comput Assist Tomogr 2009;33:247-52.
69. Grenouillet F, Botterel F, Crouzet J et al. Scedosporium prolificans: an emerging pathogen in France? Med Mycol 2009;47:343-50.
70. Li JY, Yong TY, Grove DI et al. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient. Transpl Infect Dis 2008;10:63-5. (Pubitemid 351171314)
71. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A et al. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob Agents Chemother 2007;51:748-51. (Pubitemid 46185300)
72. Gilgado F, Serena C, Cano J et al. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006;50:4211-3. (Pubitemid 44865174)
73. Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection 2011; In press.
74. Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 2008;52:1136-9. (Pubitemid 351358399)
75. Carod-Artal FJ, Ferreira-Coral L, Mauro-Couto J et al. Chronic spinal epidural abscess caused by Scedosporium prolificans in an immunocompetent patient. Spine (Phila Pa 1976) 2009;34:330-2.
76. Heyn K, Tredup A, Salvenmoser S et al. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother 2005;49:5157-9. (Pubitemid 41778940)
77. Rodriguez MM, Calvo E, Serena C et al. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother 2009;53:2153-5.
78. Walsh TJ, Groll A, Hiemenz J et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004;10(Suppl 1):48-66. (Pubitemid 38379951)
79. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003;37:728-32. (Pubitemid 37100817)
80. Lat A, Thompson GR III, Rinaldi MG et al. Micafungin concentrations from brain tissue and pancreatic pseudocyst fluid. Antimicrob Agents Chemother 2010;54:943-4.
81. Groll AH, Mickiene D, Petraitis V et al. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits. Antimicrob Agents Chemother 2001;45:3322-7. (Pubitemid 33107841)